THORATEC IMPLANTABLE VENTRICULAR ASSIST DEVICE (IVAD)

Ventricular (assist) Bypass

FDA Premarket Approval P870072 S027

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the thoratec implantable ventricular assist device (ivad) as an alternate vad blood pump for use in the approved thoratec ventricular assist device system. The device, as modified, will be marketed under the trade name thoratec implantable ventricular assist device and is indicated for use in bridge to transplant patients who meet all of the following criteria: candidate for cardiac transplantation, imminent risk of dying before donor heart procurement, dependence on, or incomplete response to, continued vasopressor support. It is also indicated for postcardiotomy recovery patients who are unable to be weaned from cardiopulmonary bypass. In addition, the ivad is designed to be compatible with both the dual driver console and tlc-ii portable vad driver.

DeviceTHORATEC IMPLANTABLE VENTRICULAR ASSIST DEVICE (IVAD)
Classification NameVentricular (assist) Bypass
Generic NameVentricular (assist) Bypass
ApplicantTHORATEC LABORATORIES CORP.
Date Received2004-01-06
Decision Date2004-08-03
PMAP870072
SupplementS027
Product CodeDSQ
Advisory CommitteeCardiovascular
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address THORATEC LABORATORIES CORP. 2023 Eighth St. berkeley, CA 94710
Post-Approval Study:Show Report Schedule and Study Progress

Supplemental Filings

Supplement NumberDateSupplement Type
P870072Original Filing
S062 2016-05-16 30-day Notice
S061 2015-12-23 30-day Notice
S060 2015-05-07 30-day Notice
S059 2014-02-18 30-day Notice
S058 2013-11-26 30-day Notice
S057 2013-11-21 Special (immediate Track)
S056 2013-07-05 30-day Notice
S055 2013-07-02 Normal 180 Day Track
S054 2013-05-16 Normal 180 Day Track
S053 2013-04-22 Real-time Process
S052 2013-02-28 30-day Notice
S051 2012-10-31 30-day Notice
S050 2012-10-03 Normal 180 Day Track
S049 2012-05-30 30-day Notice
S048 2012-05-21 30-day Notice
S047 2011-02-11 30-day Notice
S046 2010-12-27 Normal 180 Day Track No User Fee
S045 2010-09-14 Real-time Process
S044 2010-08-18 Normal 180 Day Track
S043 2010-02-12 Real-time Process
S042 2009-09-04 Real-time Process
S041 2009-02-23 Normal 180 Day Track No User Fee
S040 2008-04-21 Real-time Process
S039 2007-12-27 Special (immediate Track)
S038
S037 2007-07-30 Real-time Process
S036 2007-04-16 Real-time Process
S035 2006-09-14 Normal 180 Day Track
S034 2006-07-12 Real-time Process
S033 2004-12-27 Normal 180 Day Track No User Fee
S032
S031 2004-10-28 30-day Notice
S030 2004-09-29 Real-time Process
S029 2004-02-23 Normal 180 Day Track No User Fee
S028 2004-03-03 Real-time Process
S027 2004-01-06 Normal 180 Day Track
S026 2003-07-03 Real-time Process
S025 2003-03-10 Real-time Process
S024 2002-12-11 Special (immediate Track)
S023 2002-12-03 Normal 180 Day Track
S022 2002-09-30 Special (immediate Track)
S021 2002-09-06 Normal 180 Day Track
S020 2002-08-16 Normal 180 Day Track
S019 2002-03-27 Special (immediate Track)
S018 2001-10-22 Normal 180 Day Track
S017 2001-08-01 Normal 180 Day Track
S016 2001-06-29 Normal 180 Day Track
S015 2001-06-07 Normal 180 Day Track
S014
S013 2000-10-30 Normal 180 Day Track
S012 2000-09-25 Normal 180 Day Track
S011 2000-04-24 Normal 180 Day Track
S010 2000-04-11 Normal 180 Day Track
S009 1998-11-17 Normal 180 Day Track
S008
S007 1998-07-13 30-day Notice
S006 1997-12-22 Normal 180 Day Track
S005 1997-10-06 Panel Track
S004 1997-05-28 Real-time Process
S003 1996-10-18 Normal 180 Day Track
S002 1996-04-08 Special (immediate Track)
S001 1996-01-30 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.